Literature DB >> 22278153

Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy.

E Urso1, M Agostini, S Pucciarelli, M Rugge, R Bertorelle, I Maretto, C Bedin, E D'Angelo, C Mescoli, M Zorzi, A Viel, G Bruttocao, B Ferraro, F Erroi, P Contin, G L De Salvo, D Nitti.   

Abstract

The reported incidence of hereditary colorectal cancers (CRCs) is widely variable. The principal aim of the study was to prospectively evaluate the incidence of familial CRCs in a region of northern Italy using a standardized method. Consecutive CRC patients were prospectively enrolled from October 2002 to December 2003. Patients underwent a structured family history, the microsatellite instability (MSI) test and a screen for MUTYH mutations. Following family history patients were classified as belonging to high, moderate and mild risk families. Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 proteins and investigation for MLH1/MSH2 mutations, for MLH1 promoter methylation and for the V600E hotspot BRAF mutation were performed in high MSI (MSI-H) cases. Of the 430 patients enrolled, 17 (4%) were high risk [4 hereditary non-polyposis colorectal cancer (HNPCC), 12 suspected HNPCC and 1 MUTYH-associated adenomatous polyposis coli (MAP)], 53 moderate risk and 360 mild risk cases. The MSI test was performed on 393 tumours, and 46 (12%) of them showed MSI-H. In these patients, one MLH1 pathogenetic mutations and two MSH2 pathogenetic mutations were found. Thirty-two (70%) MSI-H cases demonstrated MLH1 methylation and/or BRAF mutation: None of them showed MLH1/MSH2 mutation. Two biallelic germline MUTYH mutations were found, one with clinical features of MAP. A strong family history of CRC was present in 4% of the enrolled cases; incidence of MLH1/MSH2 or MUTHY mutations was 1.3% and of MSI-H phenotype was 12%. MLH1 methylation and BRAF mutation can exclude 70% of MSI-H cases from gene sequencing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278153     DOI: 10.1007/s13277-011-0312-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  Limitations of family cancer history assessment at initial surgical consultation.

Authors:  L Ruo; C Cellini; J P La-Calle; M Murray; H T Thaler; S H Quan; J G Guillem
Journal:  Dis Colon Rectum       Date:  2001-01       Impact factor: 4.585

2.  Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis.

Authors:  Riccardo Nascimbeni; Salvatore Pucciarelli; Diego Di Lorenzo; Emanuele Urso; Claudio Casella; Marco Agostini; Donato Nitti; Bruno Salerni
Journal:  Dis Colon Rectum       Date:  2010-12       Impact factor: 4.585

3.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

4.  Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.

Authors:  Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger
Journal:  J Natl Cancer Inst       Date:  2004-11-03       Impact factor: 13.506

5.  Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.

Authors:  J G Park; H F Vasen; K J Park; P Peltomaki; M Ponz de Leon; M A Rodriguez-Bigas; J Lubinski; N E Beck; M L Bisgaard; M Miyaki; J T Wijnen; S Baba; H T Lynch
Journal:  Dis Colon Rectum       Date:  1999-06       Impact factor: 4.585

6.  A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.

Authors:  Marco Agostini; Maria Vittoria Enzo; Luca Morandi; Chiara Bedin; Silvia Pizzini; Silvia Mason; Roberta Bertorelle; Emanuele Urso; Claudia Mescoli; Mario Lise; Salvatore Pucciarelli; Donato Nitti
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

7.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.

Authors:  I-J Kim; J-L Ku; H C Kang; J-H Park; K-A Yoon; Y Shin; H-W Park; S G Jang; S-K Lim; S Y Han; Y-K Shin; M R Lee; S-Y Jeong; H-R Shin; J S Lee; W-H Kim; J-G Park
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

8.  Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.

Authors:  Francesc Balaguer; Sergi Castellví-Bel; Antoni Castells; Montserrat Andreu; Jenifer Muñoz; Javier P Gisbert; Xavier Llor; Rodrigo Jover; Rafael de Cid; Victòria Gonzalo; Xavier Bessa; Rosa M Xicola; Elisenda Pons; Cristina Alenda; Artemio Payá; Josep M Piqué
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  2 in total

1.  Biallelic MUTYH mutations can mimic Lynch syndrome.

Authors:  Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

2.  Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas.

Authors:  George Kunnackal John; Vipin Das Villgran; Christine Caufield-Noll; Francis Giardiello
Journal:  Fam Cancer       Date:  2020-09-11       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.